Abstract
Monogenic diabetes arises due to mutation in a single-gene and is recognized by their striking familial inheritance pattern. This form of diabetes is inherited in an autosomal dominant or recessive fashion, unlike polygenic Type 1 (autoimmune) or type 2 diabetes caused by the combined action of more than one gene [1-11]. Monogenic diabetes is classified into three main groups: Neonatal diabetes mostly presents in the first six months of birth, maturity onset diabetes of the young (MODY) and maternally inherited mitochondrial diabetes. These mutations run in the family and have a predictable course. Most of the monogenic diabetes is treated with oral medications like sulfonylurea rather than insulin. ABCC8/KCNJ11 gene mutations also cause monogenic diabetes. This gene mutation has been found in ~50% of congenital hyperinsulinemia (CHI) patients. In such cases diabetes commonly presents in the neonatal period (transient or permanent) or at adolescence / early adulthood [1]. We present a 58-year-old diabetic lady, who was detected with ABCC8 mutation during the cascade testing [8]. She was diagnosed with diabetes at the age of 12 [8]. Her son had history of neonatal hypoglycaemia and developed diabetes at the age of 15. He was the index case who was found to have ABCC8 mutation. The family has several other members diagnosed with diabetes. The aim of the article is to increase awareness and understanding of monogenic diabetes among the medical practitioners in adult population with diabetes so that the genetic testing can be offered in a cost effective manner.
Highlights
The physiological regulation of insulin release from the pancreatic beta-cells is fairly well understood
This study showed that those cases who did not have remission after six months would go on to have permanent neonatal diabetes
A recent case series of a 10-year follow- up of individuals with KCNJ11 or ABCC8 variants treated with SU agents reported that 93% of cases remained on SU therapy alone, achieving glycemic targets and with a good safety profile
Summary
The physiological regulation of insulin release from the pancreatic beta-cells is fairly well understood. Understanding the molecular basics of Insulin secretion from the pancreatic beta-cell in response to the rise in plasma glucose has paved the way for identifying a variety of mutations causing monogenic diabetes. In β- cells, the main stimulus for insulin release is elevated blood glucose levels following a meal. The postprandial plasma glucose enters the Karunakaran V, Wei C and Bano G | Volume 1; Issue 1 (2020) | Mapsci-JEMR-1(6)-006| Review Article Citation: Karunakaran V, Wei C and Bano G. Monogenic Diabetes due to ABCC8/KCNJ11 Mutation: Case Study and Review of Literature.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.